• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎相关鼻黏膜变化:来自炎症和上皮细胞分析的见解

COVID-19-associated changes in nasal mucosa: Insights from inflammatory and epithelial cell profiling.

作者信息

Donkada Pranav, Vishnu B, Murugan Senthil, Sesham Kishore, Bakshi Satvinder S, Kalidoss Vinothkumar, Francis Yuvaraj Maria, Kasirajan Sankaran Ponnusamy

机构信息

MBBS (Final Year) Student, All India Institute of Medical Sciences (AIIMS), Mangalagiri, Andhra Pradesh, India.

Department of Anatomy, All India Institute of Medical Sciences (AIIMS), Mangalagiri, Andhra Pradesh, India.

出版信息

J Family Med Prim Care. 2025 Jul;14(7):2861-2866. doi: 10.4103/jfmpc.jfmpc_185_25. Epub 2025 Jul 21.

DOI:10.4103/jfmpc.jfmpc_185_25
PMID:40814518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12349818/
Abstract

BACKGROUND

Coronavirus disease of 2019 (COVID-19), caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily affects nasal cavities by binding its spike proteins to angiotensin-converting enzyme 2 (ACE2) receptors. This study aimed to assess inflammatory and epithelial cell counts and determine their ratios in exfoliated nasal mucosal cells of COVID-19 suspected patients.

METHODOLOGY

This cross-sectional study was conducted at All India Institute of Medical Sciences (AIIMS), Mangalagiri, from August to October 2022, involving 75 COVID-19 suspected patients. Nasal smears were collected, stained with Papanicolaou test (PAP), and analyzed for inflammatory and epithelial cell counts. Participants were grouped as COVID-19 positive and negative based on Real Time Polymerase Chain Reaction (RT-PCR) results. Genotoxicity factors were evaluated using mean and standard deviation values.

RESULTS

In COVID-19 positive individuals, mean cell counts for neutrophils, eosinophils, lymphocytes, mast cells, macrophages, and epithelial cells were 42.08, 6.68, 4.48, 0.84, 0.12, and 45.80, respectively. In COVID-19 negative patients, the corresponding values were 38.08, 13.76, 11.12, 2.66, 0.22, and 34.16. The inflammatory ratios for neutrophils to eosinophils and neutrophils to lymphocytes in COVID-19 positive individuals were 7.30 and 14.06, respectively. SARS-CoV-2 infection resulted in elevated neutrophil and epithelial cell counts and decreased eosinophil, lymphocyte, mast cell, and macrophage count.

CONCLUSIONS

SARS-CoV-2 exhibits unique immunological alterations in nasal mucosa. The inflammatory ratios of neutrophils-to-eosinophils and neutrophils-to-lymphocytes may serve as reliable diagnostic markers for COVID-19.

摘要

背景

2019冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,其刺突蛋白与血管紧张素转换酶2(ACE2)受体结合,主要影响鼻腔。本研究旨在评估COVID-19疑似患者脱落鼻黏膜细胞中的炎症细胞和上皮细胞计数,并确定它们的比例。

方法

本横断面研究于2022年8月至10月在芒格莱吉的全印度医学科学研究所(AIIMS)进行,纳入75例COVID-19疑似患者。采集鼻涂片,用巴氏染色法(PAP)染色,并分析炎症细胞和上皮细胞计数。根据实时聚合酶链反应(RT-PCR)结果将参与者分为COVID-19阳性和阴性两组。使用均值和标准差评估遗传毒性因素。

结果

COVID-19阳性个体中,中性粒细胞、嗜酸性粒细胞、淋巴细胞、肥大细胞、巨噬细胞和上皮细胞的平均细胞计数分别为42.08、6.68、4.48、0.84、0.12和45.80。COVID-19阴性患者的相应值分别为38.08、13.76、11.12、2.66、0.22和34.16。COVID-19阳性个体中中性粒细胞与嗜酸性粒细胞以及中性粒细胞与淋巴细胞的炎症比例分别为7.30和14.06。SARS-CoV-2感染导致中性粒细胞和上皮细胞计数升高,嗜酸性粒细胞、淋巴细胞、肥大细胞和巨噬细胞计数降低。

结论

SARS-CoV-2在鼻黏膜中表现出独特的免疫改变。中性粒细胞与嗜酸性粒细胞以及中性粒细胞与淋巴细胞的炎症比例可能是COVID-19可靠的诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/bf4f00dbaa71/JFMPC-14-2861-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/e355fc36289e/JFMPC-14-2861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/a4a574fc1169/JFMPC-14-2861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/204e2b05d0be/JFMPC-14-2861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/2635b24a4a6b/JFMPC-14-2861-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/bf4f00dbaa71/JFMPC-14-2861-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/e355fc36289e/JFMPC-14-2861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/a4a574fc1169/JFMPC-14-2861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/204e2b05d0be/JFMPC-14-2861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/2635b24a4a6b/JFMPC-14-2861-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8904/12349818/bf4f00dbaa71/JFMPC-14-2861-g005.jpg

相似文献

1
COVID-19-associated changes in nasal mucosa: Insights from inflammatory and epithelial cell profiling.新型冠状病毒肺炎相关鼻黏膜变化:来自炎症和上皮细胞分析的见解
J Family Med Prim Care. 2025 Jul;14(7):2861-2866. doi: 10.4103/jfmpc.jfmpc_185_25. Epub 2025 Jul 21.
2
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
3
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
The nasal microbiome modulates risk for SARS-CoV-2 infection.鼻腔微生物群调节感染新型冠状病毒的风险。
EBioMedicine. 2025 May;115:105660. doi: 10.1016/j.ebiom.2025.105660. Epub 2025 Apr 9.
8
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
9
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.常规实验室检测对预测 SARS-CoV-2 感染者死亡和病情恶化为重症或危重症 COVID-19 的准确性。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015050. doi: 10.1002/14651858.CD015050.pub2.
10
Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.韩国住院COVID-19患者淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变异株的差异
J Korean Med Sci. 2025 Jul 28;40(29):e172. doi: 10.3346/jkms.2025.40.e172.

本文引用的文献

1
Exploratory Study on Micronuclei and Metanuclear Abnormalities in Exfoliated Buccal Cells of COVID-19 Suspected Patients.新型冠状病毒肺炎疑似患者脱落颊黏膜细胞微核及核异常的探索性研究
J Cytol. 2024 Jan-Mar;41(1):28-33. doi: 10.4103/joc.joc_53_23. Epub 2023 Dec 28.
2
The regulatory role of eosinophils in viral, bacterial, and fungal infections.嗜酸性粒细胞在病毒、细菌和真菌感染中的调节作用。
Clin Exp Immunol. 2022 Jul 22;209(1):72-82. doi: 10.1093/cei/uxac038.
3
Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases.
中性粒细胞与淋巴细胞比值:免疫系统与疾病关系的新兴标志物。
Int J Mol Sci. 2022 Mar 26;23(7):3636. doi: 10.3390/ijms23073636.
4
Evaluation of the Diagnostic Accuracy of Nasal Cavity and Nasopharyngeal Swab Specimens for SARS-CoV-2 Detection via Rapid Antigen Test According to Specimen Collection Timing and Viral Load.根据样本采集时间和病毒载量,通过快速抗原检测评估鼻腔和鼻咽拭子样本对SARS-CoV-2检测的诊断准确性
Diagnostics (Basel). 2022 Mar 14;12(3):710. doi: 10.3390/diagnostics12030710.
5
Parosmia post COVID-19: an unpleasant manifestation of long COVID syndrome.新冠后嗅觉异常:长期新冠综合征的一种不良表现。
Postgrad Med J. 2022 Mar;98(e2):e96. doi: 10.1136/postgradmedj-2021-139855.
6
The role of peripheral blood eosinophil counts in COVID-19 patients.外周血嗜酸性粒细胞计数在 COVID-19 患者中的作用。
Allergy. 2021 Feb;76(2):471-482. doi: 10.1111/all.14465. Epub 2020 Jul 13.
7
Eosinophil responses during COVID-19 infections and coronavirus vaccination.COVID-19 感染和冠状病毒疫苗接种期间的嗜酸性粒细胞反应。
J Allergy Clin Immunol. 2020 Jul;146(1):1-7. doi: 10.1016/j.jaci.2020.04.021. Epub 2020 Apr 25.
8
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.中国湖北省外指定传染病医院的 COVID-19 疫情。
Allergy. 2020 Jul;75(7):1742-1752. doi: 10.1111/all.14309. Epub 2020 Apr 17.
9
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
10
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.